510(k) Report

510(k) · Cleared

Cleared

EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)

K242821510(k) TraditionalCleared Feb 20, 2025155-day reviewClass II21 CFR 892.2080

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ever Fortune.Ai, Co., Ltd. · QAS Radiological Computer-Assisted Triage And Notification Software

Cleared on Feb 20, 2025 as substantially equivalent to K221330 (Aidoc Medical, Ltd., 2022) after a 155-day review. Its family tree reaches back 6 generations to 2018.

Decided
Feb 20, 2025
Review
155 days
Class
Class II
Product code
QAS
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to DEN170073 (2018). 9 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 6 generations backDEN170073 ContaCTViz.Al, Inc. · 2018
  2. 5 generations backK180647 BriefCaseAidoc Medical, Ltd. · 2018
  3. 4 generations backK190072 BriefCaseAidoc Medical, Ltd. · 2019
  4. 3 generations backK201020 BriefCaseAidoc Medical, Ltd. · 2020
  5. 2 generations backK203508 BriefCaseAidoc Medical, Ltd. · 2020
  6. 1 generation backK221330 BriefCaseAidoc Medical, Ltd. · 2022
  7. This deviceK242821 EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)Ever Fortune.Ai, Co., Ltd. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6DEN170073ContaCTViz.Al, Inc.2018—
−5K180647BriefCaseAidoc Medical, Ltd.2018—
−4K190072BriefCaseAidoc Medical, Ltd.2019—
−3K201020BriefCaseAidoc Medical, Ltd.2020—
−2K203508BriefCaseAidoc Medical, Ltd.2020—
−1K221330BriefCaseAidoc Medical, Ltd.2022—
0 (this device)K242821EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)Ever Fortune.Ai, Co., Ltd.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
201920
202010
FIG. 1 — Lineage of K242821, 2018–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QAS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QAS device

  1. #1 K203508 BriefCasescore 25.5 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K221330BriefCase
Summary page 5
…‭QAS‬ ‭Regulatory Class‬ ‭II‬ ‭3. ‭Predicate Device ‭Proprietary Name‬ ‭Briefcase‬ ‭Premarket Notification‬ ‭K221330‬ ‭Classification Name‬ ‭Radiological computer-assisted triage and notification software‬ ‭Regulation Number‬…
Aidoc Medical, Ltd.2022—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 3 companies; a new generation was cleared every 1.4 years on median.
  • None of the 9 ancestors has a recall.

How does its category compare?

All QAS devices

QAS Radiological Computer-Assisted Triage And Notification Software: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · QAS

15in 2025

2018: 32019: 52020: 122021: 52022: 152023: 112024: 122025: 152026 (partial year): 11
2007high 15 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QAS

101in 2025

2019: 111 days median2020: 112 days median2021: 86 days median2022: 116 days median2023: 98 days median2024: 136 days median2025: 101 days median2026 (partial year): 104 days median
2007high 136 (2024) · low 86 (2021)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QAS

No recall names QAS since 2007.

Adverse event reports per year · QAS

No MAUDE report names QAS since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20183—00
2019511100
20201211200
202158600
20221511600
2023119800
20241213600
20251510100
2026111040—

What is it indicated for?

EFAI CHESTSUITE XR MALPOSITIONED ETT ASSESSMENT SYSTEM (EFAI ETTXR) is a radiological computer-aided triage and notification software indicated for use in the analysis of chest X-ray (CXR) images in adults. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communicating suspected positive cases of vertically malpositioned endotracheal tube (ETT) in relation to the carina.…

Read the full statement (237 words)

EFAI CHESTSUITE XR MALPOSITIONED ETT ASSESSMENT SYSTEM (EFAI ETTXR) is a radiological computer-aided triage and notification software indicated for use in the analysis of chest X-ray (CXR) images in adults. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communicating suspected positive cases of vertically malpositioned endotracheal tube (ETT) in relation to the carina. Findings are flagged when the ETT distal tip is assessed as being more than 7 cm above the carina, less than 3 cm above the carina, or when it is below the carina (i.e in the right or left mainstem bronchus). The device assesses solely the vertical position of the ETT distal tip relative to the carina, does not factor patient positioning, and cannot detect esophageal intubation. The device is tested in the single lumen endotracheal tube, while it may trigger a false prioritization alert in the case of properly positioned double lumen ETT.

EFAI ETTXR analyzes cases using deep learning algorithms to identify suspected malpositioned ETT findings. It makes case-level output available to a PACS/workstation for worklist prioritization or triage. EFAI ETTXR is not intended to direct attention to specific portions of an image or to anomalies of an image. Its results are not intended to be used on a stand-alone basis for clinical decision-making nor is it intended to rule out malpositioned ETT or otherwise preclude clinical assessment of chest radiographs.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K242821: EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K242821

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026